Novartis in the lead to acquire cancer drug developer MorphoSys 

Novartis in the lead to acquire cancer drug developer MorphoSys

Feb 06, 2024 by Business & Finance | Reuters News Agency

Key Facts

  • Business & Finance 06 February 2024, 9:40 pm 1 minute Reuters exclusively reported that drug maker Novartis AG (NOVN
  • S) is in advanced talks to acquire MorphoSys AG (MORG
  • DE), a developer of cancer treatments that has a market value of 1.6 billion euros ($1.7 billion).
  • MARKET IMPACT MorphoSys shares rose more than 40% on the news.

Click To Read Full Article

LOCATION
MONEY
PERCENT
ORGANIZATION
MISCELLANEOUS

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.

Was this content valuable for you?